DOW CHEMICAL CO /DE/
SC 13D/A, 1996-06-03
CHEMICALS & ALLIED PRODUCTS
Previous: COMCAST CORP, SC 13D/A, 1996-06-03
Next: STRATTON MONTHLY DIVIDEND SHARES INC, 497J, 1996-06-03



                              
                              
                              
                              
                              
             SECURITIES AND EXCHANGE COMMISSION
                  Washington, D. C.  20549
                              
                              
                       SCHEDULE 13D/A
          Under the Securities Exchange Act of 1934
                       Amendment No. 2
                              
                              
                     UNIVAR CORPORATION
                       (Name of Issuer)
                              
                              
         COMMON STOCK, par value $0.33 1/3 per share
               (Title of Class of Securities)
                              
                         913353 10 8
                       (CUSIP Number)
                              
                              
                        John Scriven
             Vice President and General Counsel
                  The Dow Chemical Company
                       2030 Dow Center
                   Midland, Michigan 48674
                      (517) 636-5914
        (Name, Address and Telephone Number of Person
      Authorized to Receive Notices and Communications)
                              
                              
                              
                        May 31, 1996
   (Date of Event which Requires Filing of this Statement)



If the filing person has previously filed a statement on
Schedule 13G to report the acquisition which is the subject
of this Schedule 13D, and is filing this Schedule because of
Rule 13d-1(b)(3) or (4), check the following box [   ].


Check the following box if a fee is being paid with this
statement [  ].


                    CUSIP No. 913353 10 8


1)  Name of Reporting Person and its            The Dow Chemical Company
    I.R.S. Identification No.                   I.R.S. Identification No.
                                                38-1285128.


2)  Check the Appropriate Box if a              (a)     [  ]
    Member of a Group                           (b)     [X ]


3)  SEC Use Only


4)  Source of Funds                             WC


5)  Check Box if Disclosure of Legal
    Proceedings is Required Pursuant            [    ]
    to Items 2(d) or 2(e)


6)  Citizenship or Place of Organization        Delaware


Number of       7)  Sole Voting Power           4,409,370;  19.8%(1)
Shares
Beneficially    8) Shared Voting Power          0
Owned by
Each            9) Sole Dispositive Power       4,409,370;  19.8%(1)
Reporting
Person With    10) Shared Dispositive Power     0


11) Aggregate Amount Beneficially               4,409,370;  19.8%(1)
    owned by Each Reporting Person
    as of May 31, 1996

12) Check Box if the Aggregate Amount           [   ]
    in Row (11) Excludes Certain Shares


13) Percent of Class Represented by             19.8%(1)
    Amount in Row (11) as of
    May 31, 1996


14) Type of Reporting Person                    CO

(1)  Dow owns 3,900,000 shares, constituting 17.9%, of the
Issuer's Common Stock, and Dow has granted the Issuer a put,
and the Issuer has granted Dow a call, for up to 101,874
shares of nonvoting Series A Junior Participating
Convertible Preferred Stock of the Issuer which is
convertible by Dow into 509,370 shares of Common Stock of
the Issuer.

This Schedule 13D relates to the Common Stock, $0.33 1/3 par
value per share (the "Common Stock"), of Univar Corporation,
a Delaware corporation ("Univar"), owned by The Dow Chemical
Company, a Delaware corporation ("Dow").

Amendment No. 2 to this Schedule 13D is being filed to
reflect that on May 31, 1996, Dow agreed to tender all
shares of Common Stock of Univar owned by Dow at a price of
at least  $19.45 in cash per share to a subsidiary of
Koninklijke Pakhoed N.V. ("Pakhoed") pursuant to a
Shareholder  Agreement, dated as of May 31, 1996, a copy of
which is attached as Exhibit 1 to this Amendment No. 2 and
incorporated herein by reference.

Item 2.  Identity and Background

Dow was incorporated in 1947 under Delaware law and is the
successor to a Michigan corporation of the same name
organized in 1897.  Dow is engaged in the manufacture and
sale of chemicals, plastic materials, agricultural and
consumer products, and other specialized products.  Its
principal executive offices are located at 2030 Dow Center,
Midland, Michigan  48674, telephone (517) 636-1000.  Except
as otherwise indicated by the context, the term "Dow" as
used herein means The Dow Chemical Company and its
consolidated subsidiaries.

A list of certain of Dow's Executive Officers, all having
business addressees which are the same as Dow's principal
executive offices, is set forth below:

  Chairman of the Board                   Frank P. Popoff
  President and CEO                       William S. Stavropoulos
  Financial Vice President
    and Chief Financial Officer           J. Pedro Reinhard
  Executive Vice President                Enrique C. Falla
  Group Vice President                    Anthony J. Carbone
  Group Vice President                    Michael D. Parker

A list of Dow's Directors, their addresses and their
principal occupation or employment is noted below:

  Jacqueline K. Barton                    Barbara H. Franklin
  California Institute of Technology      Barbara Franklin Enterprises
  Division of Chem. & Chem. Engr.         2600 Virginia Avenue NW
  Mail Code 127-72                        Washington, DC 20037
  Pasadena, CA  91125

  David T. Buzzelli                       Allan D. Gilmour
  The Dow Chemical Company                The Dow Chemical Company
  2020 Dow Center                         2030 Dow Center
  Midland, MI  48674                      Midland, MI  48674

  Anthony J. Carbone                      Michael D. Parker
  The Dow Chemical Company                The Dow Chemical Company
  2020 Dow Center                         2020 Dow Center
  Midland, MI  48674                      Midland, MI  48674

  Fred P. Corson                          Frank P. Popoff
  The Dow Chemical Company                The Dow Chemical Company
  2020 Dow Center                         2020 Dow Center
  Midland, MI  48674                      Midland, MI  48674

  John C. Danforth                        J. Pedro Reinhard
  Bryan Cave LLP                          The Dow Chemical Company
  211 N. Broadway, Suite 3600             2020 Dow Center
  St. Louis, MO  63102                    Midland, MI 48674

  Willie D. Davis                         Harold T. Shapiro
  All Pro Broadcasting, Inc.              Princeton University
  161 N. LaBrea Avenue                    1 Nassau Hall
  Inglewood, CA  90301                    Princeton, NJ 08544

  Michael L. Dow                          William S. Stavropoulos
  Michael L. Dow, Associates              The Dow Chemical Company
  General Aviation Building               2020 Dow Center
  Capital City Airport                    Midland, MI 48674
  Lansing, MI  48906

  Joseph L. Downey                        Paul G. Stern
  The Dow Chemical Company                Thayer Capital Partners
  2020 Dow Center                         901 Fifteenth Street, N.W.
  Midland, MI  48674                      Washington, DC 20005

  Enrique C. Falla
  The Dow Chemical Company
  2020 Dow Center
  Midland, MI  48674

Of the foregoing Executive Officers and Directors, all are
United States citizens except J. Pedro Reinhard and Michael
D. Parker who are citizens of Brazil and Great Britain,
respectively.

During the past five years, none of the foregoing Executive
Officers or Directors has been convicted in  criminal
proceeding or been a party to a civil proceeding of a
judicial or administrative body of competent jurisdiction
which has resulted in any such Executive Officers or
Directors being made subject to a judgment, decree or final
order enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities
laws or finding any violation with respect to such laws.

Item 4.  Purpose of Transaction

(a)  Pursuant to a Shareholder Agreement, dated May 31,
     1996, by Dow in favor of Pakhoed and filed as an
     exhibit hereto and incorporated herein by reference,
     Dow agreed to tender all shares of Univar Common Stock
     owned by Dow to a subsidiary of Pakhoed at a price of
     at least $19.45 per share.  Dow further agreed, at
     Pakhoed's request, to exercise Dow's option to purchase
     101,874 shares of Series A Preferred Participating
     Convertible Preferred Shares of Univar, convert such
     preferred shares to Univar Common Stock, and tender all
     such Common Stock to a subsidiary of Pakhoed for
     purchase at a price of at least $19.45 per share.  If
     Pakhoed does not so request, Pakhoed will cause Univar
     to pay Dow the difference between the aggregate
     exercise price of the option and the aggregate price
     that would have been paid in the tender offer for the
     Univar Common Stock that would have been issued upon
     conversion of the preferred shares to Common Stock.

(b)-(j)   Not applicable.



Item 5.  Interest in Securities of the Issuer

(a)-(b)   Not applicable.

(c)  Pursuant to a Shareholder Agreement, dated May 31,
     1996, by Dow in favor of Pakhoed and filed as an
     exhibit hereto and incorporated herein by reference,
     Dow agreed to tender all shares of Univar Common Stock
     owned by Dow to a subsidiary of Pakhoed at a price of
     at least $19.45 per share.  Dow further agreed, at
     Pakhoed's request, to exercise Dow's option to purchase
     101,874 shares of Series A Preferred Participating
     Convertible Preferred Shares of Univar, convert such
     preferred shares to Univar Common Stock, and tender all
     such Common Stock to a subsidiary of Pakhoed for
     purchase at a price of at least $19.45 per share.  If
     Pakhoed does not so request, Pakhoed will cause Univar
     to pay Dow the difference between the aggregate
     exercise price of the option and the aggregate price
     that would have been paid in the tender offer for the
     Univar Common Stock that would have been issued upon
     conversion of the preferred shares to Common Stock.

(d)  Not applicable.

(e)  Not applicable.

Item 6.  Contracts, Arrangements, Understandings or
     Relationships with Respect to Securities of the Issuer

     Pursuant to a Shareholder Agreement, dated May 31,
     1996, by Dow in favor of Pakhoed and filed as an
     exhibit hereto and incorporated herein by reference,
     Dow agreed to tender all shares of Univar Common Stock
     owned by Dow to a subsidiary of Pakhoed at a price of
     at least $19.45 per share.  Dow further agreed, at
     Pakhoed's request, to exercise Dow's option to purchase
     101,874 shares of Series A Preferred Participating
     Convertible Preferred Shares of Univar, convert such
     preferred shares to Univar Common Stock, and tender all
     such Common Stock to a subsidiary of Pakhoed for
     purchase at a price of at least $19.45 per share.  If
     Pakhoed does not so request, Pakhoed will cause Univar
     to pay Dow the difference between the aggregate
     exercise price of the option and the aggregate price
     that would have been paid in the tender offer for the
     Univar Common Stock that would have been issued upon
     conversion of the preferred shares to Common Stock.

Item 7.  Material to be filed as Exhibits

     (1)  Shareholder Agreement, dated May 31, 1996, by Dow
     in favor of Pakhoed.



                          SIGNATURE
                              
After due inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is
true, complete and correct.


Dated:  June 3, 1996             THE DOW CHEMICAL COMPANY


                                 By:  /s/ J. Pedro Reinhard
                                 Name:     J. Pedro Reinhard
                                 Title:    Financial Vice President
                                           and Chief Financial Officer


                              
Exhibit 1



                    SHAREHOLDER AGREEMENT
                        MAY 31, 1996



Koninklijke Pakhoed, N.V.
333 Blaak
3011 G.B. Rotterdam
The Netherlands


Gentlemen:

In consideration for the proposed tender offer for shares of
Common Shares of Univar Corporation ("Company") to be made
by a subsidiary of yours (the "Buyer") and to be followed by
the merger of Company with Buyer (the "Merger"), the
undersigned agrees that, in its capacity as a shareholder of
Company, it will:

a)   tender all shares of Company Common Shares held of
  record or beneficially by it (representing all shares as to
  which the undersigned has sole or shared voting power) as of
  the date hereof or hereinafter acquired to Buyer pursuant to
  Buyer's proposed Offer to Purchase Shares;

b)   provide all consents and approvals pursuant to the
  Distributor Agreement by and between the undersigned and Van
  Waters & Rogers, Inc., dated March 8, 1996, required to
  consummate the Merger and the transactions contemplated by
  the Agreement and Plan of Reorganization among you, Company
  and Buyer; and

c)   only at your request, (i) exercise its option to
  purchase all or such portion required of the 101,874 shares
  of Series A Junior Participating Convertible Preferred
  Shares (the "Preferred Shares"), which the undersigned is
  entitled to purchase pursuant to the Amended and Restated
  Agreement of Purchase and Sale of Stock (the "Stock Purchase
  Agreement") entered into by and between the undersigned and
  Company, dated May 13, 1994, (ii) convert all the Preferred
  Shares the undersigned acquires pursuant to the Stock
  Purchase Agreement into Company Common Shares, and (iii)
  tender all shares of Company Common Shares acquired pursuant
  to such conversion of the Preferred Shares to Buyer pursuant
  to Buyer's proposed Offer to Purchase Shares.  If such
  request is not made and the option is not exercised, you
  will pay to us or cause the surviving corporation to pay us
  on consummation of the Merger, the difference between the
  aggregate exercise price of the option to acquire the
  Preferred Shares and the aggregate price that would have
  been paid in the tender offer for the shares of Common
  Shares which would have been issued pursuant to the
  conversion of the Preferred Shares.

Notwithstanding any other provision of this letter, the
undersigned will be relieved of its obligations under
paragraphs (a), (b) and (c) above if (i) a competing offer
to purchase the Company and/or its shares of Common Shares
at a price greater than $19.45 per share is made by a third
party prior to consummation of the Merger, or (ii) Buyer's
price for the purchase of the undersigned's shares of Common
Stock pursuant to the Offer to Purchase is adjusted to a
price which is less than $19.45 per share.

Sincerely yours,

THE DOW CHEMICAL COMPANY


By:  /s/ Michael D. Parker
Name:  Michael D. Parker
Title:  Group Vice President






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission